SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Two Sigma Advisers LP

Two Sigma Advisers LP cut its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 80.6% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 187,900 shares of the exchange traded fund’s stock after selling 780,400 shares during the period. Two Sigma Advisers LP owned 0.25% of SPDR S&P Biotech ETF worth $18,565,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently bought and sold shares of the company. Healthcare of Ontario Pension Plan Trust Fund raised its holdings in shares of SPDR S&P Biotech ETF by 198.6% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock worth $911,825,000 after buying an additional 6,138,000 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd purchased a new position in SPDR S&P Biotech ETF in the 3rd quarter worth $141,284,000. Affinity Asset Advisors LLC lifted its position in SPDR S&P Biotech ETF by 105.4% during the 2nd quarter. Affinity Asset Advisors LLC now owns 37,550 shares of the exchange traded fund’s stock worth $3,481,000 after acquiring an additional 737,550 shares during the period. Mirae Asset Securities USA Inc. purchased a new stake in SPDR S&P Biotech ETF during the 2nd quarter valued at about $55,626,000. Finally, Assetmark Inc. increased its holdings in shares of SPDR S&P Biotech ETF by 72,653.0% in the third quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock valued at $58,223,000 after purchasing an additional 588,489 shares during the period.

SPDR S&P Biotech ETF Stock Up 1.9 %

Shares of NYSEARCA XBI opened at $99.14 on Monday. SPDR S&P Biotech ETF has a 52 week low of $77.50 and a 52 week high of $105.47. The business’s 50 day moving average price is $98.22 and its 200 day moving average price is $96.87. The firm has a market cap of $7.56 billion, a P/E ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.